{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:15:43Z","timestamp":1771305343081,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020141","name":"Akebia Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.4158\/accr-2019-0366","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T17:16:05Z","timestamp":1583342165000},"page":"e79-e85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Unusual Presentations of LMNA-Associated Lipodystrophy with Complex Phenotypes and Generalized Fat Loss: When the Genetic Diagnosis Uncovers Novel Features"],"prefix":"10.1016","volume":"6","author":[{"given":"Natalia Xavier S.","family":"de Andrade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman Cem","family":"Adiyaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernamir","family":"De Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla T.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelwahab Jalal","family":"Eldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basak Ozgen","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Altay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Bhave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Onay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sermin","family":"Ozkal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Secil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Nuri","family":"Yenerel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baris","family":"Akinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif A.","family":"Oral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2019-0366_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.4158\/ACCR-2019-0366_bb0015","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2019-0366_bb0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12020-019-01862-8","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy","volume":"64","author":"Oral","year":"2019","journal-title":"Endocrine"},{"key":"10.4158\/ACCR-2019-0366_bb0025","unstructured":"GoldenJK.Myalept (metreleptin for injection). Clinical Review. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/125390Orig1s000MedR.pdf. Accessed February 15, 2020."},{"key":"10.4158\/ACCR-2019-0366_bb0030","unstructured":"ColmanEC.Myalept\/metreleptin. Summary Review. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/125390Orig1s000SumR.pdf. Accessed February 15, 2020."},{"key":"10.4158\/ACCR-2019-0366_bb0035","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2337\/dc18-0978","article-title":"\u201cFat Shadows\u201d from DXA for the qualitative assessment of lipodystrophy: when a picture is worth a thousand numbers","volume":"41","author":"Meral","year":"2018","journal-title":"Diabetes Care"},{"key":"10.4158\/ACCR-2019-0366_bb0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jc.2017-02078","article-title":"A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p.T10I mutation","volume":"103","author":"Hussain","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2019-0366_bb0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jmg.2003.015651","article-title":"Novel lamin A\/C gene (LMNA) mutations in atypical progeroid syndromes","volume":"41","author":"Csoka","year":"2004","journal-title":"J Med Genet"},{"key":"10.4158\/ACCR-2019-0366_bb0050","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ajmg.a.38341","article-title":"Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C","volume":"173","author":"Patni","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.4158\/ACCR-2019-0366_bb0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fendo.2018.00458","article-title":"Homozygous and heterozygous nuclear lamin A p.R582C mutation: different lipodystrophic phenotypes in the same kindred","volume":"9","author":"Montenegro","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.4158\/ACCR-2019-0366_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.metabol.2017.04.010","article-title":"Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy","volume":"72","author":"Akinci","year":"2017","journal-title":"Metabolism"},{"key":"10.4158\/ACCR-2019-0366_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/humu.21361","article-title":"Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations","volume":"32","author":"Scharner","year":"2011","journal-title":"Hum Mutat"},{"key":"10.4158\/ACCR-2019-0366_bb0070","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ahj.2007.07.038","article-title":"High yield of LMNA mutations in patients with dilated cardiomyopathy and\/or conduction disease referred to cardiogenetics outpatient clinics","volume":"154","author":"van Tintelen","year":"2007","journal-title":"Am Heart J"},{"key":"10.4158\/ACCR-2019-0366_bb0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jmg.2004.023283","article-title":"In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients","volume":"42","author":"Sylvius","year":"2005","journal-title":"J Med Genet"},{"key":"10.4158\/ACCR-2019-0366_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/excr.1997.3735","article-title":"Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A\/C and B1 genes","volume":"236","author":"Lin","year":"1997","journal-title":"Exp Cell Res"},{"key":"10.4158\/ACCR-2019-0366_bb0085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0145-2126(90)90076-L","article-title":"Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells","volume":"14","author":"Stadelmann","year":"1990","journal-title":"Leuk Res"},{"key":"10.4158\/ACCR-2019-0366_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520300511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520300511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:40Z","timestamp":1762497100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060520300511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2376060520300511"],"URL":"https:\/\/doi.org\/10.4158\/accr-2019-0366","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual Presentations of LMNA-Associated Lipodystrophy with Complex Phenotypes and Generalized Fat Loss: When the Genetic Diagnosis Uncovers Novel Features","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2019-0366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}